More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A SOBR Safe, Inc. Filed by: Corley Thomas John
-
Form 425 Akoya Biosciences, Inc. Filed by: Akoya Biosciences, Inc.
-
Form 8-K TD SYNNEX CORP For: Jan 08
-
Form 8-K IAC Inc. For: Jan 15
-
Form 144 ROKU, INC Filed by: Jedda Dan
-
Form 144 J.Jill, Inc. Filed by: Spofford Claire
-
Form 144 Adaptimmune Therapeutics Filed by: Bertrand William C JR
-
Form 8-K INTRUSION INC For: Jan 15
-
Form 8-K COGENT COMMUNICATIONS For: Jan 09
-
Form 4 BENCHMARK ELECTRONICS For: Jan 13 Filed by: Benck Jeff
-
Form 8-K Concentra Group Holdings For: Jan 09
-
Form 4 Direct Digital Holdings, For: Dec 13 Filed by: Walker Mark D
-
Form SCHEDULE 13D/A MINIM, INC. Filed by: HITCHCOCK JEREMY P.
-
Form 497AD Fundrise Real Estate
-
Form 4 MINIM, INC. For: Dec 26 Filed by: HITCHCOCK ELIZABETH CASH
-
Form 4 MINIM, INC. For: Dec 26 Filed by: HITCHCOCK JEREMY P.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Dorman Products, Inc. For: Jan 13 Filed by: BERMAN STEVEN L
-
Form D/A SM Fountainhead Tower
-
Form 6-K Evogene Ltd. For: Jan 15
-
Form 424B2 UBS AG
-
Form 424B2 CITIGROUP INC
-
Form 4 ADTRAN Holdings, Inc. For: Jan 13 Filed by: STANTON THOMAS R
-
Form 497AD Fundrise Growth Tech
-
Form 6-K AGNICO EAGLE MINES LTD For: Jan 15
-
Form ABS-15G MF1 REIT III LLC For: Jan 15
-
Form 424B2 MORGAN STANLEY
-
Form 4 Cibus, Inc. For: Jan 14 Filed by: Prante Gerhard
-
Form 424B2 CITIGROUP INC
-
Form 8-K GLOBAL TECH INDUSTRIES For: Jan 15
-
Form CERT Tidal Trust II
-
Form 424B2 MORGAN STANLEY
-
Form 4 UNIFIRST CORP For: Jan 13 Filed by: Zemlin Raymond C.
-
Form 10-K RED TRAIL ENERGY, LLC For: Sep 30
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 144 Adaptimmune Therapeutics Filed by: Piccina Cintia
-
Form C MPI Digital HR, LLC
-
Form D/A ICM Opportunity Fund
-
Form 424B2 CITIGROUP INC
-
Form 40-17G Forethought Variable
-
Form D/A Public Market Co-Invest
-
Form 10-Q NEOGEN CORP For: Nov 30
-
Form D PRESIDIO INVESTORS HV
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K Glass House Brands Inc. For: Jan 15
-
Form D/A OPC Opportunity Fund I
-
Form 424B2 UBS AG
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 144 Adaptimmune Therapeutics Filed by: Norry Elliot
-
Form 8-K METTLER TOLEDO INTERNATI For: Jan 09

